Practices
Education
- J.D., Washington & Lee University School of Law, 1979
- B.A., Princeton University, 1975
Bar Admissions
- New York (1980)
- Virginia (1979)
News
- Pryor Cashman Represents MDRNA, Inc. In Registered Direct Offering of Common Stock and Warrants
- Partner Lawence Remmel Speaks To US Banker About Emerging Market Woes
- Pryor Cashman Team Closes Biotechnology Financing
- Pryor Cashman Represents JP Morgan Chase Bank, N.A. In Redemption Facility Closing
- Pryor Cashman Is First To Close International Investment Company Redemption Financing
- Pryor Cashman Represented The Purchaser In The Biggest NYC Commercial Property Sale Of 2007
- Pryor Cashman Closes $1.8 Billion Record-Size Office Building Transaction in Record Time
- Pryor Cashman Assists Biotechnology Investment Company in Formation and Investments
- Pryor Cashman Represents Nastech Pharmaceuticals in Drug Development Deal with Amylin Pharmaceuticals
- Pryor Cashman Team Negotiates Supply Agreement Between Nastech Pharmaceuticals and Procter & Gamble
- Pryor Cashman Represents Nastech Pharmaceutical in Business Expansion Transactions
Print Email this page Vcard Attorneys
Lawrence Remmel
Partnerlremmel@pryorcashman.com
New York, NY 10036-6569
Lawrence Remmel specializes in corporate and banking financings, 1940 Act transactions, and asset securitizations, including securitizations involving the biotechnology industry. His work frequently involves intellectual property and licensing issues, in particular in the biotechnology area. Larry has worked on joint ventures, intellectual property transfers and supply and manufacturing agreements. He has been a partner at the firm since 1988.
Larry’s representative transactions include:
- Development of Securitized Unregistered Bio-Technology Limited Enhanced™ units, a novel means of securitizing pharmaceutical royalty cash flows
- The Bel Air film financing, providing off-balance sheet studio financing for a renewable slate of films
- Formation of the New Ventures Fund I biotech private equity fund, providing funding to late stage biotechnology companies
Larry provides daily counsel to MDRNA, Inc. f/k/a Nastech Pharmaceutical Company and regularly works with JPMorgan Chase Bank N.A. on Investment Company Act of 1940 transactions, including facilities advised by Deutsche Investment Management Americas. He also lectures from time to time at JPMorgan Chase on the 1940 Act.
Previous Positions
- Reboul, MacMurray, Hewitt, Maynard & Kristol, Associate (1984-88)
- Carter, Ledyard & Milburn, Associate (1979-84)
Speaking Engagements
- Panelist, Jefferies Life Sciences Conference on Structuring Biotech Licenses (June 2006)
Professional Affiliations
- New York State Bar Association
